Skip to main content

Evidence-Based Supplement Research

Evidence-Based Supplement Research

Lactobacillus reuteri DSM 17938 and Reduced Length of Hospital Stay

Doses used in studies

CFU/day: 100 million (median 100 million, IQR 100 million–100 million) — 1 study

1 of 1 paper

Effects of Lactobacillus reuteri DSM 17938 in preterm infants: a double-blinded randomized controlled study
- 2019-11-09
- RCT · n = 114
- Italian Journal of Pediatrics 45(1)
- - Xuewei Cui
  - Yongyan Shi
  - Siyang Gao
  - Xindong Xue
  - Jianhua Fu
- PubMed: 31706331
- DOI: 10.1186/s13052-019-0716-9
16 Insights on
- Reduced Length of Hospital Stay
- High evidence
- Rigorous Journal
the length of hospital stay was shorter than that in the control group (20.60 ± 5.36 d vs. 23.75 ± 8.57 d, P < 0.05).
Effect
Beneficial
Effect size
Moderate
Significant
Yes
Dose
1 × 10^8 colony-forming units (5 drops) once daily